57 related articles for article (PubMed ID: 20298736)
1. Manic switch and serotonin syndrome induced by augmentation of paroxetine with methylphenidate in a patient with major depression.
Park YM; Jung YK
Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):719-20. PubMed ID: 20298736
[No Abstract] [Full Text] [Related]
2. Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient.
Liau CH; Shen WW; Su KP
Psychiatry Clin Neurosci; 2006 Feb; 60(1):121-2. PubMed ID: 16472373
[No Abstract] [Full Text] [Related]
3. Severe serotonin toxicity and manic switch induced by combined use of tramadol and paroxetine.
John AP; Koloth R
Aust N Z J Psychiatry; 2007 Feb; 41(2):192-3. PubMed ID: 17484083
[No Abstract] [Full Text] [Related]
4. [Paroxetine augmentation with risperidone in therapy-resistant depression].
Knopf U; Hubrich-Ungureanu P; Thome J
Psychiatr Prax; 2001 Nov; 28(8):405-6. PubMed ID: 11721229
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
[TBL] [Abstract][Full Text] [Related]
6. Mirtazapine-induced manic switch in adolescent unipolar depression.
Goyal N; Sinha VK
Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
[No Abstract] [Full Text] [Related]
7. Rapid cycling triggered by pindolol augmentation of paroxetine, but not with desipramine.
Kraus RP
Depression; 1996; 4(2):92-4. PubMed ID: 9160648
[TBL] [Abstract][Full Text] [Related]
8. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
[TBL] [Abstract][Full Text] [Related]
9. Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient.
Hébant B; Guillaume M; Desbordes M; Gaillon G; Maltête D; Lefaucheur R
Rev Neurol (Paris); 2016 Dec; 172(12):788-789. PubMed ID: 27838092
[No Abstract] [Full Text] [Related]
10. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
Krol DG; Nolen WA
Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033
[TBL] [Abstract][Full Text] [Related]
11. Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depression.
Fagiolini A; Buysse DJ; Frank E; Houck PR; Luther JF; Kupfer DJ
J Clin Psychopharmacol; 2001 Oct; 21(5):474-8. PubMed ID: 11593071
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate-induced mania in a prepubertal child.
Koehler-Troy C; Strober M; Malenbaum R
J Clin Psychiatry; 1986 Nov; 47(11):566-7. PubMed ID: 3771504
[TBL] [Abstract][Full Text] [Related]
13. Serotonin syndrome after a massive overdose of controlled-release paroxetine.
Muzyk AJ; Jakel RJ; Preud'homme X
Psychosomatics; 2010; 51(5):437-42. PubMed ID: 20833944
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
Daléry J; Aubin V
Encephale; 2001; 27(1):71-81. PubMed ID: 11294041
[TBL] [Abstract][Full Text] [Related]
15. Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.
Hwang JP; Yang CH; Tsai SJ
Int J Geriatr Psychiatry; 2004 Feb; 19(2):189-90. PubMed ID: 14758586
[No Abstract] [Full Text] [Related]
16. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
Ghaemi SN
Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
[TBL] [Abstract][Full Text] [Related]
17. Combined antidepressant treatment: a risk factor for switching in bipolar patients.
Gabbay V; O'Dowd MA; Asnis GM
J Clin Psychiatry; 2002 Apr; 63(4):367; author reply 367-8. PubMed ID: 12000212
[No Abstract] [Full Text] [Related]
18. Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression.
Morishita S; Arita S
Hum Psychopharmacol; 2003 Aug; 18(6):479-82. PubMed ID: 12923828
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
20. [Switch to mania].
Ohgake S; Iyo M
Ryoikibetsu Shokogun Shirizu; 2003; (38):379-80. PubMed ID: 12877007
[No Abstract] [Full Text] [Related]
[Next] [New Search]
